Versions Compared


  • This line was added.
  • This line was removed.
  • Formatting was changed.
Comment: CCSA Editing



The Cancer Genome Atlas (TCGA) Ovarian Phenotype Research Group is part of the


Cancer Imaging Project TCGA Radiology Initiativefocused on analyzing images from the TCGA-ovarian (OV) collections. Images which correlate to the


ovarian serous cystadenocarcinoma (OSC) tissue data in

the TCGA

TCGA’s Data Portal are

continuing to be

being gathered for submission to The Cancer Imaging Archive (TCIA).

According to the TCGA page on Ovarian serous cystadenocarcinomaOSC, TCGA researchers have:

  • Confirmed that mutations in gene TP53 are present in more than 96 percent of ovarian cases. The TP53 gene encodes a tumor suppressor protein that normally prevents cancer development.
  • Analyzed gene expression patterns and found signatures that correlate with poor or better survival. Patients whose tumors showed a gene expression pattern associated with poor survival lived a period 23 percent shorter than patients without that signature.
  • Affirmed the existence of four distinct subtypes of ovarian cancer through examination of RNA transcription and DNA methylation patterns.
  • Substantiated observations Observed that patients with mutations in their BRCA1 and BRCA2 genes have better odds of survival than patients without mutations in those genes. Approximately 21 percent of tumor cases in this study exhibited BRCA1 and BRCA2 mutations.
  • Identified therapeutic opportunities by searching for existing drugs that might correct a genomic error that causes a patient's ovarian cancer. The search yielded 68 genes that could be targeted by existing Food and Drug Administration-approved or experimental therapeutic compounds.


Per TCGA and TCIA Guidelines, formal permission requests are still required to submit publications using TCGA-OV data.  Please see the following links for more information about the freedom-to-publish criteria for these data sets:

Data Source


TCGA Data Portal Publication Guidelines

No restrictions; all data available without limitations.

TCIA Data Usage Policies and Restrictions

Projects have not reached 100 imaging cases; Please please check with prior to any publication.

Please contact us at if you have any questions about these policies.


Imaging Source Site (ISS) Groups will be populated and governed by participants from institutions that have provided imaging data to the archive for a given cancer type. Modeled after TCGA analysis groups, these ISS groups are given the opportunity to publish a marker paper for a given cancer type per the aforementioned publication policy. It is hoped that this type per TCGA Publication Guidelines. This opportunity will generate increased participation in the building of these multi-institutional data sets that as they become an open community resource.  Current  Current TCGA-OV source sites include:


Please contact Dr. Evis Sala ( if you have scientific questions you would like to direct to the TCGA-OV ISS, or are interested in collaborating with their group.


The following links contain publications from the main TCGA project , as well as their posted publication guidelines.: